Guidelines : Migraine (prevention)
Detail
Condition :
Migraine (prevention)
Keywords :
migraine days, episodic, chronic, Fremanezumab, Eptinezumab, Botulinum toxin A, Erenumab, Galcanezumab, Rimegepant
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
05 March 2025
The Surrey Heartlands Area Prescribing Committee agreed to adopt the updated South West London (SWL) migraine prophylaxis high cost drug pathway for chronic and episodic migraine.
N/A
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Migraine (prevention).
- Amitriptyline Green
- Atogepant Red
- Botulinum toxin A Red
- Candesartan Green
- Clonidine Non Formulary
- Eptinezumab Red
- Erenumab Red
- Flunarizine Red
- Fremanezumab Red
- Gabapentin Non Formulary
- Galcanezumab Red
- Pizotifen Green
- Pregabalin Non Formulary
- Propranolol Green
- Rimegepant Red
- Topiramate Green